Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 18/20 | 0.64 |
| ▸ | SLC6A2 | P23975 | 13/20 | 0.64 |
| ▸ | SLC6A3 | Q01959 | 12/20 | 0.64 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.64 |
| ▸ | TACR1 | P25103 | 5/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9026665 | 0.96 | SLC6A4 (0.63) | SLC6A4SLC6A2SLC6A3CYP2D6TACR1 | |
| SCHEMBL8885644 | 0.91 | SLC6A2 (0.52) | SLC6A4SLC6A2SLC6A3CYP2D6TACR1 | |
| SCHEMBL9027921 | 0.88 | SLC6A4 (0.67) | SLC6A4SLC6A2SLC6A3CYP2D6TACR1 | |
| SCHEMBL9028250 | 0.86 | SLC6A4 (0.50) | SLC6A4SLC6A2SLC6A3CYP2D6TACR1 | |
| SCHEMBL9028807 | 0.84 | SLC6A4 (0.67) | SLC6A4SLC6A2SLC6A3CYP2D6TACR1 | |
| SCHEMBL9026645 | 0.81 | SLC6A4 (0.68) | SLC6A4SLC6A2SLC6A3CYP2D6TACR1 | |
| SCHEMBL8458076 | 0.78 | SLC6A4 (1.00) | SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL9027453 | 0.78 | SLC6A4 (0.68) | SLC6A4SLC6A2SLC6A3CYP2D6TACR1 | |
| SCHEMBL8881940 | 0.78 | SLC6A2 (0.55) | SLC6A4SLC6A2SLC6A3CYP2D6KCNH2 | |
| SCHEMBL9028214 | 0.76 | SLC6A4 (0.67) | SLC6A4SLC6A2SLC6A3CYP2D6TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5563133-A | NERVOUS SYSTEM DISORDERS | ELI LILLY AND COMPANY (US) | 1996-10-08 | — | — | US | disclosed |
| EP-0714891-A1 | Heterocyclic tachykinin receptor antagonists | ELI LILLY AND COMPANY (US) | 1996-06-05 | — | — | EP | disclosed |